Back to Trades
Holden Stuart
DirectorCIK 0001763999
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Holden Stuart, Director, has filed 3 SEC reports (2025–2026), all concentrated in UroGen Pharma Ltd. (URGN), totaling $894.8K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jun 24 | URGN UroGen Pharma Ltd. | Holden Stuart | Director | Award | $699.8K |
| Dec 1 | URGN UroGen Pharma Ltd. | Holden Stuart | Director | Exercise | $0 |
| Aug 27 | URGN UroGen Pharma Ltd. | Holden Stuart | Director | Award | $195.0K |
3 filings